Mechanism and Research Interest

Primary Biological Pathway: The “Remodelling Triad” The research utility of the Glow 70mg pen lies in the simultaneous activation of three non-overlapping repair mechanisms:

1. Angiogenesis (BPC-157): Activates the VEGFR2 pathway and NO system to establish the micro-vasculature required to supply nutrients to the repair site.

2. Chemotaxis (TB-500): Upregulates actin-sequestering proteins (Thymosin Beta-4), enabling the rapid migration of keratinocytes and fibroblasts into the wound bed.

3. Matrix Synthesis (GHK-Cu): Stimulates these recruited fibroblasts to synthesize Collagen Type I/III, Elastin, and proteoglycans (Decorin), while simultaneously inhibiting MMPs (Matrix Metalloproteinases) to prevent tissue degradation. Research utilizing this blend investigates the hypothesis that concurrent administration significantly shortens the “lag phase” of wound healing compared to sequential administration.